Preliminary Anticonvulsant and Toxicity Screening of Substituted Benzylidenehydrazinyl-N-(6-substituted benzo[d]thiazol-2-yl)propanamides

Table 6

Enzyme estimation of the selected compounds.

Compound	SGOT^a level; (IU/mL)	SGPT^b level; (IU/mL)	Alkaline phosphatase; (IU/mL)	Albumin; (mg/dL)	Bilirubin (mg/dL)
Control	85.1 ±	25.91 ± 1.13	15.59 ± 0.48	1.34 ± 0.03	1.56 ± 0.03
5h^*	84.9 ± 2.21	25.81 ± 1.65	14.98 ± 0.87	1.46 ± 0.09	1.49 ± 0.07
5p^*	85.6 ± 1.76	25.94 ± 1.56	11.56 ± 0.36	1.58 ± 0.06	1.55 ± 0.03
PHY	86.3 ± 4.12	26.91 ± 2.20	13.98 ± 0.72	1.52 ± 0.02	1.57 ± 0.02

Number of animals tested ( = 6), serum glutamate oxaloacetate transaminase, ^bserum glutamate pyruvate transaminase, versus control. The mean levels were calculated using ANOVA followed by Dunnett’s.